Drug industry writers propose code of ethical conduct

A group of pharmaceutical industry writers is urging all drug companies to adopt a new code of conduct that gives guidance on ethical publication practice.

The code, called Good Publication Practice for Pharmaceutical Companies, includes a commitment to register and publish all trials and to avoid redundant or duplicate publication.

The code was discussed at last week's …